4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001661539-23-000002
CHIEF MEDICAL OFFICER sold 1,034 shares at an average $12.94 ($13,376)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trevejo Jose M. CHIEF MEDICAL OFFICER | 2023-03-17 | Sale | −504 | $13.28 | $6,693 | 8,150 | D: show line 1 in the form |
| Trevejo Jose M. CHIEF MEDICAL OFFICER | 2023-03-20 | Sale | −530 | $12.61 | $6,683 | 7,620 | D: show line 2 in the form |
| Open-market sales · 1,034 sh · avg $12.94 · $13,376 | |||||||
Loading xslF345X04/wf-form4_167944023837852.xml…